Market Insights and Analysis: Global Neuromodulation Market Overview and Projections (2024-2030)
The Global Neuromodulation Market size is estimated to grow at a CAGR of around 10.3% during the forecast period, i.e., 2024-30. The Global Neuromodulation market has experienced significant growth driven by the increasing instances of cases of neurological diseases like migraine, epilepsy, depression, etc. Also, there is an increasing demand for non-invasive surgical procedures amongst patients, owing to less amount of physical pain related to these methods.
Top leading companies in the Global Neuromodulation Market includes:
Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, NeuroSigma, Inc., Neuropace Inc., Softerix Medical Inc., Aleva Neurotherapeutics, Synapse Biomedical Inc., Theranica Bio-Electronics Ltd., Neuronetics, Axonics, Inc., Gimer Medical, Nalu Medical, Inc., Helius Medical Technologies, Inc., MicroTransponder Inc., among others.
Global Neuromodulation Market Opportunity:
Increasing Healthcare Spending in Emerging Economies to be the Market Booster— Many developing countries, including India, Australia, Brazil, and others, have started focusing on their population’s mental health. As emerging nations continue their development trajectory, they offer lucrative growth potential for the neuromodulation market. Also, there has been an enhanced increment in the cases of disorders like Alzheimer’s, Parkinson’s, etc., amongst the population across the region. It would further contribute to the rising demand for the neuromodulation solutions. Moreover, with the growing awareness and ever-improving healthcare infrastructure in these nations, market players are likely to focus their attention and investments to cater to the neurological healthcare needs, further driving the market.
Access the detailed PDF Sample report– https://www.marknteladvisors.com/query/request-sample/neuromodulation-market.html
Report Segmentation:
The market is categorized into the following segments in the report:
By Type
-Internal Neuromodulation- Market Size & Forecast 2019-2030F, USD Million
-Spinal Cord Stimulation- Market Size & Forecast 2019-2030F, USD Million
-Deep Brain Stimulation- Market Size & Forecast 2019-2030F, USD Million
-Vagus Nerve Stimulation- Market Size & Forecast 2019-2030F, USD Million
-Sacral Nerve Stimulation- Market Size & Forecast 2019-2030F, USD Million
-Gastric Electrical Stimulation- Market Size & Forecast 2019-2030F, USD Million
-External Neuromodulation- Market Size & Forecast 2019-2030F, USD Million
-Transcutaneous Electrical Nerve Stimulation (TENS)- Market Size & Forecast 2019-2030F, USD Million
-Transcranial Magnetic Stimulation (TMS)- Market Size & Forecast 2019-2030F, USD Million
-Respiratory Electrical Stimulation- Market Size & Forecast 2019-2030F, USD Million
By Application
-Neuromodulation for Spinal Cord Stimulation- Market Size & Forecast 2019-2030F, USD Million
-Chronic Pain- Market Size & Forecast 2019-2030F, USD Million
-Failed Back Surgery Syndrome (FBSS)- Market Size & Forecast 2019-2030F, USD Million
-Ischemia- Market Size & Forecast 2019-2030F, USD Million
-Neuromodulation for Deep Brain Stimulation- Market Size & Forecast 2019-2030F, USD Million
-Parkinson’s Disease- Market Size & Forecast 2019-2030F, USD Million
-Tremors- Market Size & Forecast 2019-2030F, USD Million
-Depression- Market Size & Forecast 2019-2030F, USD Million
-Others- Market Size & Forecast 2019-2030F, USD Million
-Neuromodulation for Sacral Nerve Stimulation- Market Size & Forecast 2019-2030F, USD Million
-Urine Incontinence- Market Size & Forecast 2019-2030F, USD Million
-Fecal Incontinence- Market Size & Forecast 2019-2030F, USD Million
-Neuromodulation for Vagus Nerve Stimulation- Market Size & Forecast 2019-2030F, USD Million
-Epilepsy- Market Size & Forecast 2019-2030F, USD Million
-Others- Market Size & Forecast 2019-2030F, USD Million
-Neuromodulation for Gastric Electrical Stimulation- Market Size & Forecast 2019-2030F, USD Million
Gastroparesis- Market Size & Forecast 2019-2030F, USD Million
-Obesity- Market Size & Forecast 2019-2030F, USD Million
-Neuromodulation for Transcutaneous Electrical Nerve Stimulation- Market Size & Forecast 2019-2030F, USD Million
-Treatment-Resistant Depression- Market Size & Forecast 2019-2030F, USD Million
-Others- Market Size & Forecast 2019-2030F, USD Million
-Neuromodulation for Transcranial Magnetic Stimulation- Market Size & Forecast 2019-2030F, USD Million
-Depression- Market Size & Forecast 2019-2030F, USD Million
-Migraine- Market Size & Forecast 2019-2030F, USD Million
-Neuromodulation for Respiratory Electrical Stimulation- Market Size & Forecast 2019-2030F, USD Million
-Spinal Cord Injury- Market Size & Forecast 2019-2030F, USD Million.
Explore Our Comprehensive Study Reports – https://www.marknteladvisors.com/research-library/neuromodulation-market.html
Global Neuromodulation Market Geographic Reach:
The Geographic Reach of the Global Neuromodulation Market evaluates the spread and significance of Global Neuromodulation market consumption across different regions/country, emphasizing areas with the largest market size and the most promising growth potential.
- North America: The US, Canada, Mexico
- South America: Brazil, Rest of South America
- Europe: Germany, The UK, France, Italy, Spain, Rest of Europe
- Asia-Pacific: China, Japan, India, South Korea, Australia, Rest of Asia-Pacific
- Middle East & Africa: GCC, South Africa, Rest of Middle East & Africa.
Note: If you require specific information not covered in the current report, we can provide it through customized option
Why choose Us?
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
